J&J’s Drug Unit Chief Expands Portfolio in Executive Shakeup
Johnson & Johnson’s head of pharmaceuticals, Joaquin Duato, will add the company’s consumer business to his portfolio in an executive shakeup at the U.S. health-care conglomerate. J&J said Friday that Duato, 56, will take over much of the portfolio overseen by Sandra Peterson, 59, who is retiring on Oct. 1. Duato and Paul Stoffels, who leads J&J’s drug research and development, will both be named vice chairmen of the New Brunswick, New Jersey-based company’s executive committee.
Source:: https://finance.yahoo.com/news/j-js-drug-unit-chief-201543381.html
